Legacy Wealth Asset Management LLC Grows Holdings in Haleon plc (NYSE:HLN)

Legacy Wealth Asset Management LLC raised its position in shares of Haleon plc (NYSE:HLN) by 3.0% during the 1st quarter, Holdings Channel.com reports. The firm owned 70,329 shares of the company’s stock after purchasing an additional 2,045 shares during the period. Legacy Wealth Asset Management LLC’s holdings in Haleon were worth $597,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of HLN. Wellington Management Group LLP increased its stake in Haleon by 164.6% in the 4th quarter. Wellington Management Group LLP now owns 13,542,346 shares of the company’s stock worth $111,454,000 after buying an additional 8,423,475 shares in the last quarter. Cambiar Investors LLC bought a new position in Haleon in the 4th quarter worth approximately $15,225,000. Goldman Sachs Group Inc. boosted its position in shares of Haleon by 19.1% during the fourth quarter. Goldman Sachs Group Inc. now owns 4,813,997 shares of the company’s stock worth $39,619,000 after acquiring an additional 772,829 shares during the last quarter. Optiver Holding B.V. boosted its holdings in shares of Haleon by 223.0% during the 4th quarter. Optiver Holding B.V. now owns 1,008,565 shares of the company’s stock valued at $8,260,000 after purchasing an additional 696,327 shares during the last quarter. Finally, Clearbridge Investments LLC grew its holdings in shares of Haleon by 2.4% in the fourth quarter. Clearbridge Investments LLC now owns 26,581,902 shares of the company’s stock valued at $218,769,000 after purchasing an additional 612,400 shares in the last quarter. 6.67% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

HLN has been the topic of a number of research reports. Argus restated a “buy” rating on shares of Haleon in a report on Tuesday, March 26th. Berenberg Bank started coverage on Haleon in a research note on Wednesday, June 5th. They issued a “buy” rating on the stock. Finally, HSBC started coverage on shares of Haleon in a report on Wednesday, April 17th. They issued a “buy” rating on the stock. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy”.

Haleon Stock Performance

Shares of Haleon stock opened at $8.46 on Friday. The company has a current ratio of 1.04, a quick ratio of 0.73 and a debt-to-equity ratio of 0.53. The firm has a market cap of $38.63 billion, a P/E ratio of 28.20, a P/E/G ratio of 2.25 and a beta of 0.24. The stock’s fifty day moving average price is $8.41 and its 200-day moving average price is $8.35. Haleon plc has a 12 month low of $7.70 and a 12 month high of $8.96.

Haleon (NYSE:HLN) last posted its quarterly earnings data on Wednesday, May 1st. The company reported $0.12 earnings per share for the quarter, topping analysts’ consensus estimates of $0.11 by $0.01. Haleon had a return on equity of 13.17% and a net margin of 9.68%. The firm had revenue of $3.70 billion during the quarter, compared to analysts’ expectations of $3.71 billion. On average, equities research analysts expect that Haleon plc will post 0.46 earnings per share for the current fiscal year.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.